Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2018; 8(12): 104-111


Hepato-toxic Risk of Gum Arabic during Adenine-induced Renal Toxicity Prevention

Entsar A Saad, Hussam A El-Gayar, Reda S EL-Demerdash, Kholoud H Radwan.




Abstract

We aimed to highlight the potential effects of gum Arabic (GA) administration to rats with adenine (AD)-induced CRF through investigating kidney and liver changes on biochemical and histological levels. Creatinine, urea, uric acid, blood urea nitrogen (BUN), aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, bilirubin and cholesterol levels were estimated. Renal and hepatic malondialdehyde, superoxide dismutase and catalase were estimated also. Kidney and liver tissues were histo-pathologically examined. GA supplement efficiency in preventing AD-induced renal toxicity is clearly revealed. It is evident from histo-pathological examination and reduced urea, BUN, and creatinine levels. Also, it is proven that GA supplementation produces harmful effects on liver as it elevates ALT and AST levels. Thus, we conclude that GA supplement utilization to treat CKD patients must be done under medical supervision and liver function tests should be monitored during treatment course. It would be more benefit for such patients to use a hepato-protective supplement in addition to GA supplement for better outcomes.

Key words: Antioxidants; Gum Arabic; Liver damage; Nephro-protective; Renal failure.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.